Paul Schimmel, Ph.D.
DirectorataTYR Pharma· In proxies 2023–2025
Paul Schimmel, Ph.D. sits on 2 public boards.
Boards1
- aTYR PharmaDirector · 20 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- aTYR PharmaPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -94%
- Momenta, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?